Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287107 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Kamonthip Rungrojcharoenkit und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Armed Forces Health Surveillance Branch and Global Emerging Infectious Surveillance.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). RT-PCR detection of viral RNA represents the gold standard method for diagnosis of COVID-19. However, multiple diagnostic tests are needed for acute disease diagnosis and assessing immunity during the COVID-19 outbreak. Here, we developed in-house anti-RBD IgG and IgA enzyme-linked immunosorbent assays (ELISAs) using a well-defined serum sample panel for screening and identification of human SARS-CoV-2 infection. We found that our in-house anti-SARS-CoV-2 IgG ELISA displayed a 93.5% sensitivity and 98.8% specificity whereas our in-house anti-SARS-CoV-2 IgA ELISA provided assay sensitivity and specificity at 89.5% and 99.4%, respectively. The agreement kappa values of our in-house anti-SARS-CoV-2 IgG and IgA ELISA assays were deemed to be excellent and fair, respectively, when compared to RT-PCR and excellent for both assays when compared to Euroimmun anti-SARS-CoV-2 IgG and IgA ELISAs. These data indicate that our in-house anti-SARS-CoV-2 IgG and IgA ELISAs are compatible performing assays for the detection of SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Virology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
- Research Division, Royal Thai Army-Armed Forces Research Institute of Medical Sciences (RTA-AFRIMS), Bangkok, Thailand.
- Department of Internal Medicine, Kamphaeng Phet Provincial Hospital (KPPH), Kamphaeng Phet, Thailand.
ORCID-Profile: Kamonthip Rungrojcharoenkit
Förderung
- Armed Forces Health Surveillance Branch and Global Emerging Infectious Surveillance
Zitieren
APA
Rungrojcharoenkit, K., Suthangkornkul, R., Utennam, D., Buddhari, D., Pinpaiboon, S., Mongkolsirichaikul, D., Fernandez, S., Jones, A. R., Cotrone, T. S., & Hunsawong, T. (2023). Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19. PLOS ONE. https://doi.org/10.1371/journal.pone.0287107
Vancouver
Rungrojcharoenkit K, Suthangkornkul R, Utennam D, Buddhari D, Pinpaiboon S, Mongkolsirichaikul D, et al. Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19. PLOS ONE. 2023. doi:10.1371/journal.pone.0287107
BibTeX
@article{Rungrojcharoenkit2023,
author = {Rungrojcharoenkit, Kamonthip and Suthangkornkul, Rungarun and Utennam, Darunee and Buddhari, Darunee and Pinpaiboon, Soontorn and Mongkolsirichaikul, Duangrat and Fernandez, Stefan and Jones, Anthony R and Cotrone, Thomas S and Hunsawong, Taweewun},
title = {Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287107}
}
EUVIMED